---
title: “Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t
  it tell the world?”
date: '2019-12-05'
linkTitle: https://statmodeling.stat.columbia.edu/2019/12/05/pfizer-had-clues-its-blockbuster-drug-could-prevent-alzheimers-why-didnt-it-tell-the-world/
source: Statistical Modeling, Causal Inference, and Social Science
description: 'Jon Baron points to this news article by Christopher Rowland: Pfizer
  had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the
  world? A team of researchers inside Pfizer made a startling find in 2015: The company’s
  blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug,
  appeared to reduce the risk of Alzheimer’s ...'
disable_comments: true
---
Jon Baron points to this news article by Christopher Rowland: Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the world? A team of researchers inside Pfizer made a startling find in 2015: The company’s blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug, appeared to reduce the risk of Alzheimer’s ...